Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Change in Account Payables: 2016-2024

Historic Change in Account Payables for Solid Biosciences (SLDB) over the last 9 years, with Dec 2024 value amounting to $2.2 million.

  • Solid Biosciences' Change in Account Payables rose 508.21% to $815,000 in Q4 2024 from the same period last year, while for Dec 2024 it was $2.2 million, marking a year-over-year increase of 388.61%. This contributed to the annual value of $2.2 million for FY2024, which is 388.61% up from last year.
  • Per Solid Biosciences' latest filing, its Change in Account Payables stood at $2.2 million for FY2024, which was up 388.61% from -$764,000 recorded in FY2023.
  • In the past 5 years, Solid Biosciences' Change in Account Payables ranged from a high of $2.2 million in FY2024 and a low of -$5.2 million during FY2022.
  • Its 3-year average for Change in Account Payables is -$1.3 million, with a median of -$764,000 in 2023.
  • Per our database at Business Quant, Solid Biosciences' Change in Account Payables slumped by 533.91% in 2022 and then skyrocketed by 388.61% in 2024.
  • Solid Biosciences' Change in Account Payables (Yearly) stood at -$3.4 million in 2020, then surged by 135.24% to $1.2 million in 2021, then tumbled by 533.91% to -$5.2 million in 2022, then surged by 85.44% to -$764,000 in 2023, then spiked by 388.61% to $2.2 million in 2024.